AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Voglibees-GM 3 Tablet ER

Prescription Icon
Prescription Required

Marketer

Amcare Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voglibees-GM 3 Tablet ER

Diabetace-Rx 3 Extended Release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabetace-Rx 3 ER should be administered with food, consistently at the same time daily for optimal efficacy. Dosage will be determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are key to effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent adverse effect. Learn to identify its symptoms – sweating, lightheadedness, headache, trembling – and implement appropriate countermeasures. Maintain consistent mealtimes and carry readily available glucose sources like sugary snacks or juice. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician prior to commencing treatment. Pregnant or lactating individuals should seek medical counsel before initiating therapy. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Voglibees-GM 3 Tablet ER

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Voglibees-GM 3 Tablet ER

Managing type 2 diabetes

Major Benefits of Voglibees-GM 3 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Voglibees-GM 3 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.

Common Side effects of Voglibees-GM 3 Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglibees-GM 3 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Voglibees-GM 3 Tablet ER. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

How Voglibees-GM 3 Tablet ER works:

Extended-release Voglibees-GM 3 tablets contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglibees-GM 3 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Voglibees-GM 3 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Voglibees-GM 3 tablets are likely unsuitable for breastfeeding mothers. Preliminary human evidence indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Extended-release Voglibees-GM 3 tablets are likely unsafe for individuals with kidney impairment and should be avoided. Seek medical advice before use. Furthermore, their use is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Voglibees-GM 3 Tablet ER cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Voglibees-GM 3 Tablet ER :

Should you forget a Voglibees-GM 3 Tablet ER dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglibees-GM 3 Tablet ER

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Voglibees-GM 3 Tablet ER

Voglibees-GM 3 Extended-Release tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults. Effective blood sugar control requires concurrent adherence to a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood glucose elevations. This formulation is unsuitable for type 1 diabetes.
Voglibees-GM 3 Tablet ER may cause common adverse reactions including low blood glucose, nausea, diarrhea, taste disturbances, gas, abdominal pain, headache, skin eruptions, and respiratory infections.
Patients with hypersensitivity to Voglibees-GM 3 Tablet ER constituents or inactive ingredients should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Voglibees-GM 3 Tablet ER is unsafe. This combination may lead to dangerously low blood sugar and heighten the risk of lactic acidosis.
Indeed, Voglibees-GM 3 Tablet ER can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This adverse effect is heightened by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the container or label. Discard any remaining medication. Prevent access by children, pets, and others.
Voglibees-GM 3 Tablet ER
90
MRP 110
18% off